BeStock  
Stocks › VRDN

Viridian Therapeutics VRDN

US equityMarket cap rank #2720
$19.00 −$0.40 (-2.06%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $19.00 0.00%
Open$19.41
Prev close$19.40
Day range$18.83 – $19.59
Volume2.65M
Market cap$2.15B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$34.11+79.5% vs. price
  • Buy 100%
Low $22.00Now $19.00Avg $34.11High $41.00

Recent rating changes

The last 20 actions on file set price targets from $22.00 to $43.00, averaging $35.94.

DateFirmRatingTarget
2 Oct 2026 LifeSci Capital BUY $35.00
22 Sep 2026 RBC Capital BUY $38.00
1 Sep 2026 Truist Financial BUY –
19 Aug 2026 Goldman Sachs BUY $40.00
13 Aug 2026 Stifel BUY $40.00
11 Aug 2026 Truist Financial BUY $39.00
10 Aug 2026 Evercore BUY $26.00
7 Aug 2026 Truist Financial BUY $39.00
6 Aug 2026 TD Cowen BUY –
6 Aug 2026 LifeSci Capital BUY $35.00
6 Aug 2026 William Blair BUY –
6 Aug 2026 Wedbush BUY $41.00
6 Aug 2026 Needham BUY $34.00
6 Aug 2026 H.C. Wainwright BUY $22.00
6 Aug 2026 RBC Capital BUY $36.00
4 Aug 2026 Wedbush BUY $43.00
20 Jul 2026 Wells Fargo BUY $31.00
13 Jul 2026 Wedbush BUY $43.00
30 Jun 2026 Wells Fargo BUY $31.00
30 Jun 2026 Truist Financial BUY $38.00

Discussion

No comments yet — be the first to weigh in on VRDN.

Leave a comment

Scroll to Top